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Any eye surgeon, no matter how experienced, 
will occasionally encounter a serious cataract 
complication. Although complications may 
be devastating for the patient and are always 
distressing for the surgeon, are they really a 
major issue for VISION 2020? The evidence 
says that they are.
Impact
We know from numerous population-based 
surveys that a significant number of cataract 
operations may have poor outcomes (defined 
as presenting visual acuity of less than 6/60).
Poor outcomes are distressing or 
disappointing for patients. They reflect badly 
on the health or surgical facility and on the 
surgical team. Poor outcomes may also 
affect the sustainability of services; they 
discourage other patients from coming for 
surgery and make patients even more 
reluctant to contribute towards the cost of 
cataract operations. 
In general, poor vision after cataract 
surgery is caused by: inadequate correction 
of post-operative refractive error (lack of 
spectacles); failure to detect pre-existing 
eye conditions, e.g. macular degeneration 
or amblyopia (selection); or surgical 
complications (surgery). 
The widespread adoption of intraocular 
lenses is starting to decrease the number of 
patients left functionally blind after cataract 
surgery because they are not able to obtain 
the necessary aphakic correction spectacles.
Problems of selection can be addressed 
by careful pre-operative evaluation, which 
should reduce the number of poor results 
due to the presence of other eye diseases. 
This will help to prevent complications.
Surgical complications, which are the 
main focus of this issue, can to some 
extent be prevented by good practice and 
surgical technique. When complications do 
occur, proper management is crucial to 
reduce the possibility of a poor outcome 
for the patient.
There are currently no comprehensive 
figures on the proportion of poor outcomes 
of cataract surgery in developing countries 
and on the relative importance of spectacles, 
selection, and surgery (Table 1, page 2,  
provides data from Bangladesh,1 Kenya,2 
and Pakistan3). At a conservative estimate, 
at least 25% (or 1.5 million) of the six 
million cataract operations performed 
annually in developing countries will have 
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poor outcomes. About one quarter of these 
poor outcomes are due to surgical compli-
cations. Over 375,000 people can therefore 
suffer permanent visual impairment every 
year as a result of surgical complications. 
This means that surgical complications, 
and cataract complications in general, 
represent a significant obstacle to the 
success of any blindness prevention 
programme. The topics discussed in this 
issue are therefore vital to the successful 
implementation of VISION 2020.
Important complications
Many things can go wrong during or immedi-
ately after cataract surgery. It is impossible to 
address every single complication in one issue 
of the journal, so we have concentrated on 
those that we feel are important. 
What is an important complication? Some 
complications are common, but their impact 
is relatively minor. Others are rare but have a 
devastating impact. The articles in this issue 
will focus primarily on capsular rupture and 
vitreous loss, which is relatively common and 
potentially serious, and on endophthalmitis, 
which is rare but devastating. 
Does capsular rupture and vitreous loss 
matter? Even in well-equipped teaching 
hospitals in the United Kingdom, vitreous 
loss is associated with a nearly fourfold 
greater risk of a poor visual outcome.4 In 
operating theatres without vitrectomy 
equipment, the risk of a poor outcome is likely 
to be even higher. However, not every patient 
who suffers capsular rupture and vitreous 
loss experiences a poor outcome. If the 
complication is managed well, it is possible to 
retain excellent vision (see article on page 6).
In high-income countries, the incidence 
of capsular rupture and vitreous loss 
appears to be declining and is now in the 
region of 1–2%. This improvement may be 
related to the use of phacoemulsification 
and to earlier intervention, which means 
that the great majority of cataracts are now 
removed before they are mature. In low- and 
middle-income countries, however, the 
incidence of capsular rupture and vitreous 
loss appears to be higher.5 This is probably 
due to the greater complexity of many 
cataract operations in developing countries, 
rather than to specific deficiencies of 
training, expertise, or equipment used.
Vitreous loss also increases the risk of 
endophthalmitis, the most feared compli-
cation of intraocular surgery. The incidence 
of endophthalmitis may vary. Studies from 
Europe give the estimated incidence as 
0.14%.6 At Aravind Eye Hospital, in India, 
this incidence is about 0.05%.7 
The causes of endophthalmitis might vary 
with geography. In most European studies, 
Staphylococcus epidermidis is the most 
common infecting microorganism. This 
bacterium is found in normal eyelid skin and 
conjunctiva, and it enters the eye during 
surgery. However, in South India, Nocardia 
species were the commonest cause of 
infection.7 When endophthalmitis does occur, 
the prognosis is grim. In the UK, one third of 
patients who suffered this complication had 
a final visual acuity (VA) of less than 6/60, 
and 13% had lost all light perception.6 At 
Aravind Eye Hospital in India, 65% of eyes 
had VA <6/60.7 However, these figures also 
show that the prognosis following endoph-
thalmitis is by no means hopeless. 
Preventing complications
We know that certain eyes are more likely to 
suffer complications than others (see article 
on page 12). It is therefore very important to 
detect these conditions before surgery. For 
example, eyes with endothelial dystrophy 
(such as Fuch’s dystrophy and corneal 
dystrophy), pseudoexfoliation, mature 
cataracts, or high ametropia (>6 dioptres of 
myopia or hypermetropia) are all at greater 
risk than eyes without these features. 
Simple scoring systems have been devised 
to stratify patients into low, medium, and 
high risk.8 
It is important to collect data in order to 
identify patients at risk and to monitor their 
management before and after surgery. Even 
where the incidence of complications is low, 
regular collection of data helps to identify 
high-risk patients and to confirm that they 
are being managed appropriately. 
Monitoring of cataract surgical outcomes is 
associated with a reduction in the incidence 
of surgical complications.9
Some risk factors are intrinsic to the 
patient and, short of avoiding surgery 
altogether, very little can be done to 
eliminate them. However, in the event of 
surgery, high-risk cases should be operated 
on in an appropriate setting, by a surgeon 
who has the right level of experience. It has 
been shown that surgery carried out in eye 
camps, or by an inexperienced trainee, is 
more likely to result in complications than 
surgery undertaken in hospital by an experi-
enced surgeon. Therefore, if patients with 
high-risk eyes are identified, they should be 
operated on by a fully trained surgeon, 
preferably in a base hospital.
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Percentage of total 
number of operations 
leading to a poor outcome
Cause of poor outcomes
Spectacles Selection Surgery
Bangladesh 28% 37% 41% 22%
Kenya 22% 34% 36% 30%
Pakistan 34% 36% 39% 25%3 Community EyE HEaltH Journal | Vol 21 iSSuE 65 | marCH 2008
Although intrinsic risk factors cannot be 
avoided, other factors which may increase 
the risk of surgical complications are related 
to the delivery of the surgery. These latter 
risks can, and should, be modified. Much 
can be done before and during surgery to 
reduce the rate of complications.
Meticulous sterilisation of all surgical 
instruments and fluids, and careful aseptic 
technique, are of course essential. Articles 
in this issue describe important steps to 
avoid complications during small incision 
cataract surgery (page 4) and 
how to reduce the risk of 
endophthalmitis (page 9).  
Recently, a large randomised 
clinical trial has shown a 
substantial reduction in the risk 
of endophthalmitis if 1 mg of 
cefuroxime is injected into the 
anterior chamber at the 
conclusion of surgery (see 
abstract and comment on page 
11). This technique should be 
adopted universally, as it has the 
potential to save the sight of 
thousands of people per year.
The importance of 
managing complications
With all complications, including capsular 
rupture and vitreous loss, and even endoph-
thalmitis, the prognosis is better if the 
complication is managed effectively. 
Not every patient who suffers capsular 
rupture and vitreous loss experiences a poor 
outcome. If the complication is managed 
well, it is possible for the patient to retain 
excellent vision. However, we often do not 
deal with vitreous loss as well as we should. 
The article on page 6 provides top tips from 
experienced cataract surgeons for 
managing vitreous loss. In the case of 
endophthalmitis, early recognition and 
prompt treatment with intravitreal vanco-
mycin and either ceftazidime or amikacin 
seems to offer the best hope of visual recovery. 
With immediate use of intravitreal antibi-
otics, some eyes will recover useful vision.
Because complications can and will 
occur, even in the best of cases, the eye 
care team must be prepared to manage 
them efficiently. Being prepared means:  
being trained to manage the problem; 
knowing where the relevant supplies are 
kept; having the right drugs and equipment 
on hand; and ensuring that the entire team 
is aware of the protocols for dealing with a 
complication. For example, 
there should be a protocol for 
vitrectomy in case of vitreous 
loss, and appropriate 
equipment should be on site. 
If phacoemulsification is being 
used, a protocol is needed to 
deal appropriately with dropped 
nuclei. When this complication 
is managed by prompt vitrectomy 
and fragmentation of the 
nucleus, the outcomes are 
normally good. However, if the 
nuclear material is not 
removed, the eye will be 
blinded by a combination of severe inflam-
mation and glaucoma. No eye clinic should 
be using phacoemulsification unless they 
have identified a facility to which they can 
refer patients for vitrectomy and fragmen-
tation of a retained nucleus. As 
phacoemulsification becomes more 
common in low- and middle-income 
countries, the number of dropped nuclei 
will also increase. Dislocation of fragments 
of the lens nucleus into the vitreous occurs 
in approximately 0.3% of phacoemulsifi-
cation operations. The incidence may be 
higher in low- and middle-income countries, 
where dense cataracts and pseudoexfo-
liation are more common.10 
The management of complications 
needs to be incorporated into training 
programmes. For example, management of 
vitreous loss, like every other surgical skill, 
can only be learnt by practicing under the 
supervision of a more experienced surgeon. 
However, although vitreous loss is most 
likely to occur while the surgeon is inexperi-
enced, when it does occur, the trainer will 
usually take over. This means that, in some 
developed countries, ophthalmologists may 
do a few hundred cataract operations during 
their training, but will only manage vitreous 
loss two or three times. 
Our training programmes rightly emphasise 
the avoidance of complications in cataract 
surgery. However, we need a greater emphasis 
on the correct management of these 
complications when they do occur, as they 
inevitably will. No trainee is truly competent 
to operate on cataract patients independently 
unless, for example, they are also competent 
in the management of vitreous loss.
Conclusion
In conclusion, the surgeon’s first responsi-
bility is to prevent complications. However, 
despite our best efforts, they will occur. Our 
next priority is to ensure that we are prepared 
to deal with these complications effectively 
so that our patients can obtain good vision, 
regardless of what went wrong during surgery. 
If we improve our management of complica-
tions, we can be certain that we will reduce 
the number of poor visual outcomes and 
disappointed cataract patients. 
In striving to reach the goals of VISION 2020, 
we must be careful to maintain a culture that 
values outcome (the quality of cataract 
operations) as highly as output (the number 
of operations performed).
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Skin cleaned with povidone-iodine (Betadine 10%) before a cataract operation. nEPal